Overview
Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions
Status:
Completed
Completed
Trial end date:
2005-01-01
2005-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under fed conditions.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Roxane LaboratoriesTreatments:
Ramipril
Criteria
Inclusion Criteria:- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme
altering drugs. History of allergic or adverse response to Ramipril or any comparable
or similar product.